I. Kasman

发表

The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis

S. Sa, P. Valdez, Jianfeng Wu, 2007, The Journal of Immunology.

Anti‐VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models

I. Kasman, A. Jubb, Mallika Singh, 2012, The Journal of pathology.

Rapid Access of Antibodies to α5β1 Integrin Overexpressed on the Luminal Surface of Tumor Blood Vessels

I. Kasman, D. McDonald, P. Baluk, 2005 .

An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

Zhaoshi Jiang, F. Peale, I. Kasman, 2013, Nature Medicine.

Blocking neuropilin-2 function inhibits tumor cell metastasis.

F. Peale, M. Tessier-Lavigne, I. Kasman, 2008, Cancer cell.

Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.

I. Kasman, G. Fuh, N. Ferrara, 2008, Investigative ophthalmology & visual science.

Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice

F. Peale, I. Kasman, W. Forrest, 2007, Proceedings of the National Academy of Sciences.

Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway

Zhaoshi Jiang, I. Kasman, Z. Modrušan, 2012, The EMBO journal.

Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma

M. Ozawa, Akiyoshi Uemura, P. Troncoso, 2005, Cancer.

Tumorigenesis and Neoplastic Progression Uniform Overexpression and Rapid Accessibility of 1 Integrin on Blood Vessels in Tumors

I. Kasman, D. McDonald, P. Parsons-Wingerter, 2005 .

Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3

K. Alitalo, I. Kasman, A. Eichmann, 2010, The Journal of cell biology.

Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels.

M. Ozawa, I. Kasman, W. Arap, 2006, Cancer research.

Intestinal Epithelial Cell Up-Regulation of LY6 Molecules during Colitis Results in Enhanced Chemokine Secretion

Arvind K. Chavali, I. Kasman, Z. Modrušan, 2008, The Journal of Immunology.

Enhanced Chemokine Secretion LY 6 Molecules during Colitis Results in Intestinal Epithelial Cell Up-Regulation of

Arvind K. Chavali, I. Kasman, Z. Modrušan, 2008 .

Mechanistic evaluation of the combination effect of anti-VEGF and chemotherapy

F. Peale, I. Kasman, R. Carano, 2008 .

Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy

I. Kasman, O. Rosen, Mallika Singh, 2010, Clinical Cancer Research.

MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival.

I. Kasman, J. Zha, Zemin Zhang, 2007, Cancer research.

Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

P. Valdez, Jianfeng Wu, I. Kasman, 2007, Nature.

PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth

Thijs J. Hagenbeek, M. Shibuya, I. Kasman, 2010, Cell.

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Serban Nacu, Manfred Westphal, Zora Modrusan, 2010, Cancer cell.

Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis

Minhong Yan, I. Kasman, Mallika Singh, 2006, Nature.

PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.

I. Kasman, Z. Modrušan, J. Kaminker, 2009, Cancer cell.

Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors.

I. Kasman, D. McDonald, P. Parsons-Wingerter, 2005, The American journal of pathology.

Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy

M. Shibuya, I. Kasman, G. Zhuang, 2011, Proceedings of the National Academy of Sciences.

EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution

I. Kasman, D. Rice, D. French, 2007, Development.

Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition.

Mark Merchant, M. Belvin, I. Kasman, 2012, Cancer research.

Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels.

I. Kasman, D. McDonald, P. Baluk, 2005, Cancer research.

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.

P. Hegde, I. Kasman, A. Jubb, 2013, The Journal of clinical investigation.

A comparison of least squares and conditional maximum likelihood estimators under volume endpoint censoring in tumor growth experiments

F. O’Sullivan, I. Kasman, K. R. Choudhury, 2012, Statistics in medicine.

Ricinus communis agglutinin I leads to rapid down-regulation of VEGFR-2 and endothelial cell apoptosis in tumor blood vessels.

I. Kasman, W. You, D. McDonald, 2010, The American journal of pathology.

A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

S. Vandenberg, M. Prados, Serban Nacu, 2010, Cancer cell.

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.

P. Hegde, I. Kasman, A. Jubb, 2013, The Journal of clinical investigation.

Abstract 3295: Inhibiting vascular morphogenesis in tumors: EGFL7 as a novel therapeutic target

I. Kasman, Mallika Singh, R. Carano, 2011 .

An interleukin-17–mediated paracrine network promotes tumor resistance to anti-angiogenic therapy

Zhaoshi Jiang, F. Peale, I. Kasman, 2013, Nature Medicine.

Analysis of multi‐arm tumor growth trials in xenograft animals using phase change adaptive piecewise quadratic models

Kingshuk Roy Choudhury, I. Kasman, K. Roy Choudhury, 2010, Statistics in medicine.

Tumorigenesis and Neoplastic Progression Ricinus communis Agglutinin I Leads to Rapid Down-Regulation of VEGFR-2 and Endothelial Cell Apoptosis in Tumor Blood Vessels

I. Kasman, W. You, D. Hu-Lowe, 2010 .